Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Aug 5, 2011

Premium

ThermoGenesis has named Robin Stracey to its board of directors, replacing Mahendra Rao who has resigned in order to take a position at the National Institutes of Health.

Stracey is the president and CEO of Cantimer. Previously he was CEO of Applied Imaging, a medical devices company that is now a part of Danaher. He was also vice president and general manager of chromatography and mass spectrometry at Thermo Fisher Scientific.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.